
Sign up to save your podcasts
Or


Dapagliflozin and HFpEF did happen to improve the composite outcome but this was based mainly on hospitalizations not on death and comes at a big price tag with the NNT around 36 at 2.3yrs.
N Engl J Med 2022; 387:1089-1098
By Questioning Medicine4.9
7474 ratings
Dapagliflozin and HFpEF did happen to improve the composite outcome but this was based mainly on hospitalizations not on death and comes at a big price tag with the NNT around 36 at 2.3yrs.
N Engl J Med 2022; 387:1089-1098

7,713 Listeners

14,827 Listeners

137 Listeners

697 Listeners

498 Listeners

259 Listeners

2,440 Listeners

3,347 Listeners

56,739 Listeners

1,145 Listeners

28,470 Listeners

6,425 Listeners

370 Listeners

29,256 Listeners

1,317 Listeners